NCT02587663View on ClinicalTrials.gov

Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

November 20, 2005

Primary Completion Date

November 20, 2011

Study Completion Date

November 20, 2012

Conditions
Ductal Breast Carcinoma In SituStage IA Breast CancerStage IB Breast CancerStage II Breast Cancer
Interventions
PROCEDURE

Contrast-enhanced Magnetic Resonance Imaging

Undergo bilateral breast contrast enhanced MRI

PROCEDURE

Mammography

Undergo bilateral mammography

PROCEDURE

Therapeutic Conventional Surgery

Undergo breast conserving surgery

PROCEDURE

Ultrasonography

Undergo bilateral whole-breast ultrasound

PROCEDURE

Ultrasonography

Undergo targeted breast ultrasound

OTHER

Gadolinium

Contrast agent used in MRI

Trial Locations (1)

90033

USC / Norris Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Southern California

OTHER

NCT02587663 - Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI | Biotech Hunter | Biotech Hunter